Morgan Stanley research has suggested that nearly a quarter of GLP-1 users stopped drinking alcohol completely
Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law
These medications mimic the effects of natural GLP-1 hormones in the body, slowing digestion and promoting a feeling of fullness, resulting in steady and sustainable weight loss
Key industry trends include a shift towards multi-ingredient formulations combining GLP-1 support with probiotics, vitamins, and botanical extracts like berberine and Ceylon cinnamon, enhancing overall efficacy and appeal
The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect